What is it about?
The COVID-19 pandemic has had profound effects on the US. Patients with end stage kidney disease are vulnerable to infectious complications. We showed that COVID-19 led to excess mortality in patients on dialysis and those with a kidney transplant.
Featured Image
Why is it important?
This study showed that rates of COVID-19 hospitalization among dialysis patients are nearly 40 times higher than in the general population, and that mortality in both dialysis and transplant patients was approximately 20% to 30% higher than usual during the second quarter of 2020. These data show that protection of this patient population, including by widespread vaccination, is critically important.
Perspectives
The United States Renal Data System offers a unique view of national outcomes in the US population of patients with end stage kidney disease. The data in this study should be used to guide political decisions.
Eric David Weinhandl
Chronic Disease Research Group
Read the Original
This page is a summary of: Initial Effects of COVID-19 on Patients with ESKD, Journal of the American Society of Nephrology, April 2021, American Society of Nephrology,
DOI: 10.1681/asn.2021010009.
You can read the full text:
Contributors
The following have contributed to this page
